PolyPeptide Attracts Buyout Interest Amid Turnaround
PolyPeptide has drawn buyout interest as its operational turnaround gains traction with potential acquirers. The development signals improving confidence in the contract peptide manufacturer's stability, with the peptide CDMO sector under heightened strategic attention due to GLP-1 drug demand. Whether a formal sale pr